Effectiveness of commercial inhibitors against subtype F HIV-1 protease (2009)
Source: Journal of Enzyme Inhibition and Medicinal Chemistry. Unidade: IFSC
Subjects: INIBIDORES DE ENZIMAS, HIV, PLANEJAMENTO DE FÁRMACOS, SÍNDROME DE IMUNODEFICIÊNCIA ADQUIRIDA, POLIMORFISMO
ABNT
KRAUCHENCO, Sandra et al. Effectiveness of commercial inhibitors against subtype F HIV-1 protease. Journal of Enzyme Inhibition and Medicinal Chemistry, v. 24, n. 3, p. 638-645, 2009Tradução . . Disponível em: https://doi.org/10.1080/14756360802321740. Acesso em: 10 nov. 2024.APA
Krauchenco, S., Martins, N. H., Sanches, M., & Polikarpov, I. (2009). Effectiveness of commercial inhibitors against subtype F HIV-1 protease. Journal of Enzyme Inhibition and Medicinal Chemistry, 24( 3), 638-645. doi:10.1080/14756360802321740NLM
Krauchenco S, Martins NH, Sanches M, Polikarpov I. Effectiveness of commercial inhibitors against subtype F HIV-1 protease [Internet]. Journal of Enzyme Inhibition and Medicinal Chemistry. 2009 ; 24( 3): 638-645.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1080/14756360802321740Vancouver
Krauchenco S, Martins NH, Sanches M, Polikarpov I. Effectiveness of commercial inhibitors against subtype F HIV-1 protease [Internet]. Journal of Enzyme Inhibition and Medicinal Chemistry. 2009 ; 24( 3): 638-645.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1080/14756360802321740